\n\t\t\t\t\t
\n\t\t\t\t\t\tATERHIT Symposium<\/h2><\/div>
ATERHIT Symposium<\/h2><\/div><\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\t![\"\"](\"https:\/\/iach2019.cme-congresses.com\/wp-content\/uploads\/2019\/08\/aterhit-logo-300x145.jpg\" "\\"\\"")
<\/span><\/div><\/div><\/div>ATERHIT supported Non-profit Lunch Symposium (Hall A)
\nSaturday, September 21st
\n11:45-12:45<\/span><\/em><\/h2><\/div><\/div><\/div>CAR T cells in lymphoid malignancies: current status and perspectives<\/span>
\nChair: Mohamad Mohty<\/strong>, France<\/span><\/h2><\/div><\/div><\/div>\n\n\n\n\n11:45<\/td>\n How to build a CAR T cells program:\u00a0Ibrahim Yakoub-Agha<\/strong>, France<\/td>\n<\/tr>\n\n12:05<\/td>\n CAR T cells in myeloma:\u00a0Mohamad Mohty<\/strong>, France<\/td>\n<\/tr>\n\n12:25<\/td>\n CAR T cells in NHL:\u00a0Arnon Nagler<\/strong>, Israel<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"yst_prominent_words":[440,465,38,28,466,21,449,443,44,450,444,441,39],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077"}],"collection":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/comments?post=12077"}],"version-history":[{"count":0,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077\/revisions"}],"wp:attachment":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/media?parent=12077"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/yst_prominent_words?post=12077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\t\t\t\t\t
\n\t\t\t\t\t\t<\/span><\/div>
<\/span><\/div><\/div>
<\/div>ATERHIT supported Non-profit Lunch Symposium (Hall A)
ATERHIT supported Non-profit Lunch Symposium (Hall A)
\nSaturday, September 21st
\n11:45-12:45<\/span><\/em><\/h2><\/div><\/div><\/div>CAR T cells in lymphoid malignancies: current status and perspectives<\/span>
\nChair: Mohamad Mohty<\/strong>, France<\/span><\/h2><\/div><\/div><\/div>\n\n\n\n\n11:45<\/td>\n How to build a CAR T cells program:\u00a0Ibrahim Yakoub-Agha<\/strong>, France<\/td>\n<\/tr>\n\n12:05<\/td>\n CAR T cells in myeloma:\u00a0Mohamad Mohty<\/strong>, France<\/td>\n<\/tr>\n\n12:25<\/td>\n CAR T cells in NHL:\u00a0Arnon Nagler<\/strong>, Israel<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"yst_prominent_words":[440,465,38,28,466,21,449,443,44,450,444,441,39],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077"}],"collection":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/comments?post=12077"}],"version-history":[{"count":0,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077\/revisions"}],"wp:attachment":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/media?parent=12077"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/yst_prominent_words?post=12077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/div>CAR T cells in lymphoid malignancies: current status and perspectives<\/span>
CAR T cells in lymphoid malignancies: current status and perspectives<\/span>
\nChair: Mohamad Mohty<\/strong>, France<\/span><\/h2><\/div><\/div><\/div>\n\n\n\n\n11:45<\/td>\n How to build a CAR T cells program:\u00a0Ibrahim Yakoub-Agha<\/strong>, France<\/td>\n<\/tr>\n\n12:05<\/td>\n CAR T cells in myeloma:\u00a0Mohamad Mohty<\/strong>, France<\/td>\n<\/tr>\n\n12:25<\/td>\n CAR T cells in NHL:\u00a0Arnon Nagler<\/strong>, Israel<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"yst_prominent_words":[440,465,38,28,466,21,449,443,44,450,444,441,39],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077"}],"collection":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/comments?post=12077"}],"version-history":[{"count":0,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077\/revisions"}],"wp:attachment":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/media?parent=12077"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/yst_prominent_words?post=12077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/div>\n
\n\n\n
| 11:45<\/td>\n | How to build a CAR T cells program:\u00a0Ibrahim Yakoub-Agha<\/strong>, France<\/td>\n<\/tr>\n| 12:05<\/td>\n | CAR T cells in myeloma:\u00a0Mohamad Mohty<\/strong>, France<\/td>\n<\/tr>\n | 12:25<\/td>\n | CAR T cells in NHL:\u00a0Arnon Nagler<\/strong>, Israel<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n | <\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"yst_prominent_words":[440,465,38,28,466,21,449,443,44,450,444,441,39],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077"}],"collection":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/comments?post=12077"}],"version-history":[{"count":0,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12077\/revisions"}],"wp:attachment":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/media?parent=12077"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/yst_prominent_words?post=12077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} |